|Grant Affiliation:||Bjorkman: Improving Potency and Breadth of Natural bNAbs|
|Strategy:||Prophylactic neutralizing Ab|
|Study Type:||Antibody Screening|
|Study Start Date:||2012-08-30|
|Study Made Public:||2015-10-19|
Improved anti-HIV-1 reagents
CAVD 385 is an immunogencity study to evaluate various engineered forms of broadly neutralizing antibodies (bNAbs) across large viral panels.
Sign in to see full information about this study and to download study data.
ProductsNo Products used in study
No integrated data is available for this study.
No non-integrated data is available for this study.